8:00 - 19:00

Working hours MON. - FRI.

EU, UK drug regulators rally behind AstraZeneca vaccine after safety concerns By Reuters

By Anthony Deutsch, Toby Sterling and Alistair Smout AMSTERDAM/LONDON (Reuters) - Drug watchdogs in the EU and Britain moved to shore up confidence in AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine on Thursday after reports of blood clots prompted more than a dozen nations to suspend inoculations. The safety scare is the latest challenge for AstraZeneca and its ambition to produce a "vaccine for the...

Continue reading

EU’s drug regulator backs ‘safe and effective’ AstraZeneca vaccine By Reuters

By Anthony Deutsch and Toby Sterling AMSTERDAM (Reuters) - The EU's drug watchdog said on Thursday it is still convinced the benefits of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine outweigh the risks following an investigation into reports of blood clots that prompted more than a dozen nations to suspend its use. The European Medicines Agency (EMA) director Emer Cooke said the watchdog could not...

Continue reading

Explainer: How worried should we be about reports of blood clots and AstraZeneca’s vaccine? By Reuters

By Ludwig Burger and Matthias Blamont FRANKFURT/PARIS (Reuters) - Europe's medicines watchdog concluded on Thursday that AstraZeneca (NASDAQ:AZN)'s coronavirus vaccine still far outweighed any risks after investigating reports of rare blood clotting disorders but said it would add a warning to the product leaflet. "A causal link with the vaccine is not proven, but is possible and deserves further analysis," the European...

Continue reading

Nikola Slumps As Partner Cuts Stake in Half By Investing.com

By Christiana SciaudoneInvesting.com --  Nikola slumped more than 6% after a strategic partner said it's dumping shares. Green Nikola Holdings/Hanwha said in a filing it would sell half of its 22 million shares in the company. The South Korean company told Reuters it will use the proceeds to invest in hydrogen-related businesses. It's yet another blow for the hydrogen truck company, whose founder...

Continue reading

Five Below Beats Expectations But Offers No Guidance on Year, Shares Fall By Investing.com

Dhirendra Tripathi Investing.com – Despite a blowout quarter, management's lack of full-year guidance sank Five Below (NASDAQ:FIVE) shares on Thursday. The stock fell 3% in morning trade. A robust outlook for February  through April was also not adequate to sooth traders’ nerves. Berenberg Bank analyst Brian McNamara maintained a hold rating on the stock and a price target of $143. This is a 24%...

Continue reading

Indian court restrains Future chief from selling assets in dispute with Amazon By Reuters

NEW DELHI (Reuters) - An Indian court on Thursday restrained Future Group chief Kishore Biyani from selling his assets following Amazon.com Inc (NASDAQ:AMZN)'s challenge against the Indian group's $3.4 billion retail assets sale. Amazon is locked in a dispute with its warring partner Future which it says allegedly violated certain contracts by selling its retail assets to market leader Reliance Industries last...

Continue reading
en_GBEnglish